FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Next-generation sequencing is reshaping how labs detect, understand, and manage disease
Explore how molecular diagnostics transform pathogen detection, providing faster, more accurate results compared to traditional testing methods
New developments in flow cytometry and molecular biology promise to improve the detection of rare cancers
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Digital and computational pathology expert Donal O’Shea explores the role of emerging technologies in addressing workforce shortages
Studies by Paige demonstrate the greater accuracy that artificial intelligence potentially offers for pathologists
Roche experts discuss the company’s recently launched automated solution and how it will bring mass spec to more patients
The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness
At-home testing is giving patients an increasingly active role in managing their health—but what does this trend mean for labs?
The value of lab test utilization management—and the ASCP’s latest best practice recommendations for effective test utilization